These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 10075615

  • 1. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
    Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME.
    Ann Intern Med; 1999 Mar 16; 130(6):478-86. PubMed ID: 10075615
    [Abstract] [Full Text] [Related]

  • 2. Etanercept: a review of its use in rheumatoid arthritis.
    Jarvis B, Faulds D.
    Drugs; 1999 Jun 16; 57(6):945-66. PubMed ID: 10400407
    [Abstract] [Full Text] [Related]

  • 3. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    Drugs; 2002 Jun 16; 62(17):2493-537. PubMed ID: 12421111
    [Abstract] [Full Text] [Related]

  • 4. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL, Chou SJ, Chen DY, Chen YH, Hsieh TY, Young M.
    J Formos Med Assoc; 2004 Aug 28; 103(8):618-23. PubMed ID: 15340661
    [Abstract] [Full Text] [Related]

  • 6. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ.
    Arthritis Rheum; 2004 Feb 28; 50(2):353-63. PubMed ID: 14872476
    [Abstract] [Full Text] [Related]

  • 7. Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    BioDrugs; 2003 Feb 28; 17(2):139-45. PubMed ID: 12641492
    [Abstract] [Full Text] [Related]

  • 8. Etanercept for the treatment of rheumatoid arthritis.
    Blumenauer B, Judd M, Cranney A, Burls A, Coyle D, Hochberg M, Tugwell P, Wells G.
    Cochrane Database Syst Rev; 2003 Feb 28; (4):CD004525. PubMed ID: 14584021
    [Abstract] [Full Text] [Related]

  • 9. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis.
    Murray KM, Dahl SL.
    Ann Pharmacother; 1997 Nov 28; 31(11):1335-8. PubMed ID: 9391689
    [Abstract] [Full Text] [Related]

  • 10. Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.
    Weinblatt M, Schiff M, Goldman A, Kremer J, Luggen M, Li T, Chen D, Becker JC.
    Ann Rheum Dis; 2007 Feb 28; 66(2):228-34. PubMed ID: 16935912
    [Abstract] [Full Text] [Related]

  • 11. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS, Nash P, Durez P, Hall S, Ilivanova E, Irazoque-Palazuelos F, Miranda P, Park MC, Pavelka K, Pedersen R, Szumski A, Hammond C, Koenig AS, Vlahos B.
    Lancet; 2013 Mar 16; 381(9870):918-29. PubMed ID: 23332236
    [Abstract] [Full Text] [Related]

  • 12. Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison.
    Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Wajdula J, Fatenejad S, Etanercept European Investigators Network (Etanercept Study 309 Investigators).
    Ann Rheum Dis; 2006 Oct 16; 65(10):1357-62. PubMed ID: 16606651
    [Abstract] [Full Text] [Related]

  • 13. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU, GO-AFTER study investigators.
    Lancet; 2009 Jul 18; 374(9685):210-21. PubMed ID: 19560810
    [Abstract] [Full Text] [Related]

  • 14. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun 18; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martín Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M, TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators.
    Lancet; 2004 Feb 28; 363(9410):675-81. PubMed ID: 15001324
    [Abstract] [Full Text] [Related]

  • 16. Etanercept for the treatment of rheumatoid arthritis.
    Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.
    Cochrane Database Syst Rev; 2013 May 31; 2013(5):CD004525. PubMed ID: 23728649
    [Abstract] [Full Text] [Related]

  • 17. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
    Schiff MH, Yu EB, Weinblatt ME, Moreland LW, Genovese MC, White B, Singh A, Chon Y, Woolley JM.
    Drugs Aging; 2006 May 31; 23(2):167-78. PubMed ID: 16536638
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness and safety of etanercept in subjects with RA who have failed infliximab therapy: 16-week, open-label, observational study.
    Bingham CO, Ince A, Haraoui B, Keystone EC, Chon Y, Baumgartner S.
    Curr Med Res Opin; 2009 May 31; 25(5):1131-42. PubMed ID: 19317607
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
    Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.
    Arthritis Rheumatol; 2015 May 31; 67(8):2240-9. PubMed ID: 25891010
    [Abstract] [Full Text] [Related]

  • 20. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.
    Hu D, Bao C, Chen S, Gu J, Li Z, Sun L, Han X, Ni L.
    Rheumatol Int; 2009 Jan 31; 29(3):297-303. PubMed ID: 18704426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.